| I-13 Nicolas Frey Model-based meta-analysis of amyloid plaque reduction in Alzheimer’s disease patients to identify new Phase 3 doses and dosing regimens for Gantenerumab Wednesday 10:20-11:40 |
| I-13 Nicolas Frey Model-based meta-analysis of amyloid plaque reduction in Alzheimer’s disease patients to identify new Phase 3 doses and dosing regimens for Gantenerumab Wednesday 10:20-11:40 |